Security National Bank’s Vertex Pharmaceuticals VRTX Stock Holding History

Security National Bank’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.96K	Hold	12	–	–	﹤0.01%	339
2026 Q1	$5.36K	Hold	12	–	–	﹤0.01%	341
2025 Q4	$5.44K	Hold	12	–	–	﹤0.01%	328
2025 Q3	$4.7K	Buy	+12	New	+$5.01K	﹤0.01%	338
2024 Q4	–	Sell	-304	Closed	-$141K	–	330
2024 Q3	$141K	Hold	304	–	–	0.02%	129
2024 Q2	$142K	Buy	304 +5	+2%	+$2.17K	0.02%	126
2024 Q1	$125K	Buy	+299	New	+$126K	0.02%	131

Other funds holding VRTX

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

CTB

Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

PensionDanmark Copenhagen O, Denmark $12B AUM

BIAS

Beacon Investment Advisory Services Morristown, New Jersey $2.69B AUM 35.07% 1-Year Est. Return

Security National Bank's VRTX Position: Q2 2026 in Review

Security National Bank held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 12 shares worth $5.96K. The position accounts for ﹤0.01% of the portfolio, ranked #339.

Security National Bank first reported a position in VRTX in Q1 2024 and has held it in 7 quarters since. The position peaked at $142K in Q2 2024. 252 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

Security National Bank held 12 shares of Vertex Pharmaceuticals worth $5.96K as of Q2 2026.
Security National Bank left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
Vertex Pharmaceuticals made up ﹤0.01% of Security National Bank's portfolio in Q2 2026, its #339 holding.
Security National Bank first reported a position in Vertex Pharmaceuticals in Q1 2024 and has held it in 7 quarters since.
Security National Bank's Vertex Pharmaceuticals position peaked at $142K in Q2 2024.
252 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Security National Bank's 13F filing for Q2 2026, filed 15 Jul 2026.